Skip to main content

Table 1 Demographic, clinical, and laboratory data of the study population

From: Evaluation of novel coronavirus disease (COVID-19) using quantitative lung CT and clinical data: prediction of short-term outcome

Demographics

 Age (years; median, range)

63.5 (26–95)

 Male (number, percentage)

65/106 (61.3)

 Female (number, percentage)

41/106 (38.7)

Clinical information

 No comorbidity (number, percentage)

66/106 (62.3)

 Presence of ≥ 1 comorbidity

40/106 (37.7)

 Duration of symptoms at computed tomography (days; median, range)

5 (1–30)

Laboratory information

 White blood cell count (109/L) (median, range)

5.7 (1.9–29.7)

 Lymphocyte (%) (median, range)

18.8 (2.2–53.0)

 C-reactive protein (mg/L) (median, range)

4.94 (0.1–28.3)

Admitted/discharged from emergency department

 Admitted

97/106 (91.5%)

 Discharged from the emergency department

9/106 (8.5%)

Outcome

 Favourable

64/106 (60.4%)

 Adverse

42/106 (39.6%)

Outcome subgroups

 Need for mechanical ventilation

17/42 (40.5%)

 Death

25/42 (59.5%)